Norland receives PMA for ultrasound bone unit

Article

Bone densitometry vendor Norland Medical Systems and its partner, U.K.-based McCue, have received premarket approval clearance from the Food and Drug Administration for CubaClinical, an ultrasound bone measurement system. CubaClinical is a dry system and

Bone densitometry vendor Norland Medical Systems and its partner, U.K.-based McCue, have received premarket approval clearance from the Food and Drug Administration for CubaClinical, an ultrasound bone measurement system. CubaClinical is a dry system and carries a large clinical database, according to Norland executives.

After terminating a two-year alliance with Canadian firm IMRO, White Plains, NY-based Norland signed an exclusive distribution and service agreement in June 1999 with McCue, which developed CubaClinical (SCAN 8/4/99). Norland distributes McCue systems in the U.S., Canada, Europe, Africa, the Middle East, and the Pacific Rim. CubaClinical lists at approximately $20,000.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.